T1	morphology-onco 432 446	adénocarcinome
T2	morphology-onco 607 621	adénocarcinome
T3	morphology-onco 642 644	M0
T4	morphology-onco 1456 1507	Métastase rétrooculaire d'une tumeur neuroendocrine
T5	morphology-onco 1509 1512	TNE
T6	morphology-onco 1786 1805	lésion métastatique
T7	morphology-onco 2031 2034	CID
T8	morphology-onco 2153 2155	M0
T9	morphology-onco 3307 3316	malignité
T10	morphology-onco 3369 3407	tumeur neuroendocrine (TNE) de type G1
T11	morphology-onco 3392 3395	TNE
T12	morphology-onco 3703 3706	NER
T13	morphology-onco 3976 3979	TNE
T14	morphology-onco 4337 4351	TNE de grade I
T15	morphology-onco 4523 4526	TNE
T16	morphology-onco 4615 4621	TNE G1
T17	morphology-onco 4689 4692	TNE
T18	morphology-onco 4970 5017	tumeur aux caractéristiques neuroendocriniennes
T19	morphology-onco 5244 5276	nodule rétro-orbitaire de 1,2 cm
T20	morphology-onco 5470 5473	NER
T21	morphology-onco 5651 5703	nodule persistant situé en arrière du globe oculaire
T22	morphology-onco 5908 5910	M1
#1	ICD-O-3.1 T7	8500/3
#2	ICD-O-3.1 T3	8000/6
#3	ICD-O-3.1 T8	8000/6
#4	ICD-O-3.1 T22	8000/6
#5	ICD-O-3.1 T1	8140/3
#6	ICD-O-3.1 T2	8140/3
#7	ICD-O-3.1 T9	8000/3
#8	ICD-O-3.1 T6	8000/6
#9	ICD-O-3.1 T10	8240/31
#10	ICD-O-3.1 T4	8240/6
#11	ICD-O-3.1 T5	8240/3
#12	ICD-O-3.1 T11	8240/3
#13	ICD-O-3.1 T12	8240/3
#14	ICD-O-3.1 T13	8240/3
#15	ICD-O-3.1 T14	8240/31
#16	ICD-O-3.1 T15	8240/3
#17	ICD-O-3.1 T16	8240/31
#18	ICD-O-3.1 T17	8240/3
#19	ICD-O-3.1 T18	8240/3
#20	ICD-O-3.1 T20	8240/3
#21	ICD-O-3.1 T19	8000/6
#22	ICD-O-3.1 T21	8000/6
#23	SNOMED T7	58477004
#24	SNOMED T3	14799000
#25	SNOMED T8	14799000
#26	SNOMED T22	14799000
#27	SNOMED T1	1187332001
#28	SNOMED T2	1187332001
#29	SNOMED T9	1240414004
#30	SNOMED T6	14799000
#31	SNOMED T10	189607006
#32	SNOMED T5	189607006
#33	SNOMED T11	189607006
#34	SNOMED T12	189607006
#35	SNOMED T13	189607006
#36	SNOMED T14	189607006
#37	SNOMED T15	189607006
#38	SNOMED T16	189607006
#39	SNOMED T17	189607006
#40	SNOMED T18	189607006
#41	SNOMED T20	189607006
#42	SNOMED T19	14799000
#43	SNOMED T21	14799000
